Joëlle Rüegg

Min forskning fokuserar på hur hormonstörande ämnen, dvs. kemikalier som interfererar med vårt hormonsystem, påverkar hjärnutvecklingen. Jag samverkar i multidisciplinära projekt för att kunna förstå ämnens hela komplexitet genom att länka molekylära mekanismer med human hälsa, och för att ta vetenskapliga insikter vidare till regulatoriska och politiska beslut. Jag är koordinator av ett sådant projekt, Horizon 2020-finanisierade ENDpoiNTs. Läs mer om min forskning här.

Diploma in Biochemistry, University of Zürich (1994-1999)

MSc in Neuroscience, University of Edinburgh (1999-2000)

PhD Ludwig Maximilian University München, (2000-2004)

Docent in Toxicology, Karolinska Institutet 2018

My research focusses on the question how early life exposure to endocrine disrupting chemicals (EDCs) affects human (neuro)development via epigenetic changes, i.e. long-lasting changes in gene regulation that do not involve alteration in the DNA sequence. In the Molecular Toxicology and Epigenetics group, we are working on four main projects:

• ENDpoiNTs, a H2020-funded research and innovation action including 16 participants, that aims at developing novel testing methods and strategies to identify chemicals that affect neurodevelopment via endocrine disrupting mechanisms.
• RACH-Mix, a Formas-funded project where we identify epigenetic changes induced by chemical mixtures and address their value as early markers for human exposure-linked disease risk.
• The Formas-funded BBB project, in which we investigate the effect of EDCs on the human blood-brain barrier using advanced in vitro models, and link our results to epidemiological findings.